The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

Patients with psoriasis without musculoskeletal involvement are 2.5 times more likely to have synovitis on imaging than control patients.

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.

The prevalence of drinking alcohol in the US has declined in recent years while belief that drinking is unhealthy has increased.

ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

Topline results were announced from a phase 3 trial evaluating Cylembio (imsapepimut and etimupepimut, adjuvanted) in combination with pembrolizumab as a first-line treatment for advanced melanoma.

Researchers have identified an association between varicose veins and central serous chorioretinopathy and serous pigment ...

Wait times for a bed exceeding 4 hours occurred in 25% of admissions from the emergency room in nonpeak months.

Patients with dermally-based leiomyosarcoma generally have a better prognosis than patients with subcutis-based leiomyosarcoma.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.